To evaluate the relevance of leupaxin expression in breast cancer, 127 tissue sections from breast cancer patients were stained with a leupaxin specific antibody and classified into low, medium and high depending on the percentage of positive cancer cells and the according leupaxin expression level. This evidence concerns the gene LPXN and breast carcinoma.